ASCO GUIDELINES Bundle

Non-Small Cell Lung Cancer Adjuvant Therapy for Completely Resected Stages I–IIIA

ASCO GUIDELINES App Bundle brought to you fcourtesy of Guideline Central. All of these titles are available for purchase on our website, GuidelineCentral.com. Enjoy!

Issue link: http://eguideline.guidelinecentral.com/i/1475486

Contents of this Issue

Navigation

Page 3 of 3

106 Commerce Street, Suite 105 Lake Mary, FL 32746 TEL: 407.878.7606 • FAX: 407.878.7611 Order additional copies at GuidelineCentral.com Copyright © 2022 All rights reserved. ASCONSCLCI02223 Disclaimer is pocket guide is derived om recommendations in the American Society of Clinical Oncolog y Guideline. is resource is a practice tool based on ASCO® practice guidelines and is not intended to substitute for the independent professional judgment of the treating physician. Practice guidelines do not account for individual variation among patients. is pocket guide does not purport to suggest any particular course of medical treatment. Use of the practice guidelines and this resource are voluntary. e practice guidelines and additional information are available at www.asco.org/thoracic-cancer- guidelines. Copyright © 2022 by American Society of Clinical Oncolog y. All rights reserved. Abbreviations ALPI, Adjuvant Lung Cancer Project Italy; ANITA, Adjuvant Navelbine International Trialist Association; CALGB, Cancer and Leukemia Group B; EGFR, epidermal growth factor receptor; IALT, International Adjuvant Lung Cancer Trial; LACE, Lung Adjuvant Cisplatin Evaluation Source Pisters K, Kris MG, Gaspar LE, et al. Adjuvant Systemic erapy and Adjuvant Radiation erapy for Stage I to IIIA Completely Resected Non-Small-Cell Lung Cancer: ASCO Guideline Rapid Recommendation Update. J Clin Oncol. 2022 Feb 15. doi:10.1200/ JCO.22.00051. Kris MG, Gaspar LE, Cha JE, et al. Adjuvant Systemic erapy and Adjuvant Radiation erapy for Stage I to IIIA Completely Resected Non-Small-Cell Lung Cancers: American Society of Clinical Oncolog y/Cancer Care Ontario Clinical Practice Guideline Update. J Clin Oncol. 2017 Sep 1;35(25):2960-2974. ASCO believes that cancer clinical trials are vital to inform medical decisions and improve cancer care and that all patients should have the opportunity to participate. Additional information, which may include data supplements, slide sets, and other clinical tools and resources, is available at www.asco.org/thoracic-cancer-guidelines.

Articles in this issue

Links on this page

Archives of this issue

view archives of ASCO GUIDELINES Bundle - Non-Small Cell Lung Cancer Adjuvant Therapy for Completely Resected Stages I–IIIA